These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7690812

  • 21. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
    Qu Z, Cheng X, de la Maza LM, Peterson EM.
    Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
    [Abstract] [Full Text] [Related]

  • 22. Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis.
    Motin VL, de la Maza LM, Peterson EM.
    Clin Diagn Lab Immunol; 1999 May; 6(3):356-63. PubMed ID: 10225836
    [Abstract] [Full Text] [Related]

  • 23. Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies.
    Murdin AD, Su H, Klein MH, Caldwell HD.
    Infect Immun; 1995 Mar; 63(3):1116-21. PubMed ID: 7532625
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections.
    Kim SK, Angevine M, Demick K, Ortiz L, Rudersdorf R, Watkins D, DeMars R.
    J Immunol; 1999 Jun 01; 162(11):6855-66. PubMed ID: 10352308
    [Abstract] [Full Text] [Related]

  • 30. Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants.
    Wolf K, Fischer E, Mead D, Zhong G, Peeling R, Whitmire B, Caldwell HD.
    Infect Immun; 2001 May 01; 69(5):3082-91. PubMed ID: 11292727
    [Abstract] [Full Text] [Related]

  • 31. Mapping of a surface-exposed B-cell epitope to the variable sequent 3 of the major outer-membrane protein of Chlamydia trachomatis.
    Pal S, Cheng X, Peterson EM, de la Maza LM.
    J Gen Microbiol; 1993 Jul 01; 139(7):1565-70. PubMed ID: 7690394
    [Abstract] [Full Text] [Related]

  • 32. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J, Boutillon C, Georges B, Ameisen JC, Tartar A, Auriault C.
    J Pept Sci; 1996 Jul 01; 2(3):165-75. PubMed ID: 9231325
    [Abstract] [Full Text] [Related]

  • 33. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H, Parnell M, Caldwell HD.
    Vaccine; 1995 Aug 01; 13(11):1023-32. PubMed ID: 8525685
    [Abstract] [Full Text] [Related]

  • 34. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.
    Bockenstedt LK, Fikrig E, Barthold SW, Flavell RA, Kantor FS.
    J Immunol; 1996 Dec 15; 157(12):5496-502. PubMed ID: 8955199
    [Abstract] [Full Text] [Related]

  • 35. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
    Wen Z, Boddicker MA, Kaufhold RM, Khandelwal P, Durr E, Qiu P, Lucas BJ, Nahas DD, Cook JC, Touch S, Skinner JM, Espeseth AS, Przysiecki CT, Zhang L.
    BMC Microbiol; 2016 Jul 27; 16(1):165. PubMed ID: 27464881
    [Abstract] [Full Text] [Related]

  • 36. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM.
    Vaccine; 2006 Feb 06; 24(6):766-75. PubMed ID: 16199110
    [Abstract] [Full Text] [Related]

  • 37. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.
    Olsen AW, Follmann F, Erneholm K, Rosenkrands I, Andersen P.
    J Infect Dis; 2015 Sep 15; 212(6):978-89. PubMed ID: 25748320
    [Abstract] [Full Text] [Related]

  • 38. Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice.
    Cruz LJ, Quintana D, Iglesias E, Garcia Y, Huerta V, Garay HE, Duarte C, Reyes O.
    J Pept Sci; 2000 May 15; 6(5):217-24. PubMed ID: 10823490
    [Abstract] [Full Text] [Related]

  • 39. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB, Glasier LM, Ellert NW, Cachia P, Kohn W, Lee KK, Paranchych W, Hodges RS, Irvin RT.
    Biomed Pept Proteins Nucleic Acids; 1995 May 15; 1(3):141-8. PubMed ID: 9346845
    [Abstract] [Full Text] [Related]

  • 40. A comparative study of different presentation strategies for an HIV peptide immunogen.
    Cruz LJ, Iglesias E, Aguilar JC, González LJ, Reyes O, Albericio F, Andreu D.
    Bioconjug Chem; 2004 May 15; 15(1):112-20. PubMed ID: 14733590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.